[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ejection-fraction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ejection-fraction":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100571776","tapering-heart-failure-medication-in-patients-with-heart-failure-with-recovered-ejection-fraction-open-label-prospective-random-trial-100571776",false,"NCT06724653","Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial","HFrecEF","Inclusion Criteria:\n\n* initial echocardiogram ejection fraction less than 40%\n* follow up echocardiogram ejection fraction over 50% and LVEDD index normal range\n* NTprobnp criteria\n\n  1. eGFR ≥60 ; less 440\n  2. eGFR 45-59: less 980\n  3. eGFR 30-44; less 1220\n  4. eGFR \\\u003C 30 : less 5300\n  5. in HD; no criteria for NTproBNP\n* on more than 3 heart failure medication ( RAS blocker, beta blocker, mineral corticoid receptor antagonist, SGLT 2 inhibitor)\n\nExclusion Criteria:\n\n1. under age 18 year\n2. uncontrolled BP ( over 150\u002F90)\n3. coronary revascularization within 6 months\n4. significant valve disease\n5. arrhythmia requiring rate control\n6. CKD with albuminuria ( over 30mg\u002Fg)\n7. Pregnancy","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","Study start date is on Nov 27th 2024.\n\nA patient with an initial ejection fraction (EF) of less than 40%, whose follow-up shows an improvement to an EF of 50% or higher, along with the left ventricular end-diastolic diameter returning to the normal range and taking 3 more heart failure medication randomed to drug tapering group ( RAS blocker or beta blocker) or continuing medication group.",[26,27,28],"Heart Failure","Ejection Fraction","Recovery of Function",[30,31],"heart failure with recovered ejection fraction","Tapering","RECRUITING","2026-03-23",{"date":35,"type":36},"2026-03-27","ACTUAL",{"date":38,"type":36},"2025-03-06",{"date":40,"type":20},"2027-11-26",{"name":42,"class":43},"Chungnam National University Hospital","OTHER",2]